References

1 NCI. Cancer Clinical Trials:  The Basic Workbook. ND [cited; Available from: http://www.cancer.gov/clinicaltrials/resources/basicworkbook/
2 Comis R, et al. A Quantitative Survey of Public Attitudes Towards Cancer Clinical Trials.  2000  [cited; Available from: http://www.cancertrialshelp.org/static_binary/308-9.pdf
3 Nathan D. The impact of clinical trials on the treatment of diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2002;87: 1929-37.
4 Comis R, Colaizzi D, Kimmel L, Miller J. The "Enrollment Enemy" Is Us:  new Findings Show Physician Attitudes a Leading Factor in Low Cancer Clinical Trial Participation.  American Society of Clinical Oncology Annual Meeting. Chicago, IL: Coalition of Cancer Cooperative Groups, Philadelphia PA & Northwestern University, Chicago IL.; 2007.
5 Comis R, Miller J, Aldige C, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. Journal of Clinical Oncology 2003;21: 830-5.
6 ACS. Detailed Guide: Ovarian Cancer.  What are the Key Statistics about Ovarian Cancer?  2007  [cited 2/14/07]; Available from: http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_are_the_key_statistics_for_ovarian_cancer_33.asp?sitearea=cri
7 ACS. Cancer Statistics 2007 [Powerpoint Presentation]: American Cancer Society, Inc.; 2007.
8 NIH. Re-engineering the Clinical Research Enterprise:  Translational Research. NIH Roadmap for Medical Research [Web Page] 2008 3/19/08 [cited 2008 4/10/08]; Available from: http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp


 

Sign up to receive our newsletter


 

Contact Ovacome USA, Inc.
Ovacome - Ovarian Cancer Advocacy & Support
P.O. Box 173427
Tampa, FL 33672-1427
Phone: 1-813-223-9108
email: ovacometampa@yahoo.com


Registered charity number 201349867
©COPYRIGHT OVACOME, 2004
Webmaster: webmaster@ovacome.org